|
CA2266656A1
(en)
|
1996-09-17 |
1998-03-26 |
Chiron Corporation |
Compositions and methods for treating intracellular diseases
|
|
EP2261347A3
(en)
|
1998-05-01 |
2012-01-11 |
Novartis Vaccines and Diagnostics, Inc. |
Neisseria meningitidis antigens and compositions
|
|
AU2109700A
(en)
|
1999-01-22 |
2000-08-07 |
Smithkline Beecham Biologicals (Sa) |
Novel compounds
|
|
US7666988B1
(en)
|
1999-03-12 |
2010-02-23 |
Glaxosmithkline Biologicals S.A. |
BASB082 Polypeptides
|
|
CA2372235A1
(en)
|
1999-04-30 |
2000-11-09 |
Rino Rappuoli |
Conserved neisserial antigens
|
|
AU783894B2
(en)
|
1999-05-19 |
2005-12-22 |
Novartis Vaccines And Diagnostics S.R.L. |
Combination neisserial compositions
|
|
EP1226253A2
(en)
|
1999-10-29 |
2002-07-31 |
Chiron S.P.A. |
Neisserial antigenic peptides
|
|
GB9928196D0
(en)
|
1999-11-29 |
2000-01-26 |
Chiron Spa |
Combinations of B, C and other antigens
|
|
CA2871789C
(en)
|
2000-01-17 |
2017-04-04 |
Novartis Vaccines And Diagnostics S.R.L. |
Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
|
|
MXPA02007184A
(es)
*
|
2000-01-25 |
2004-02-26 |
Univ Queensland |
Proteinas que comprenden regiones conservadas de antigenos de superficie nhha de neisseria meningitidis.
|
|
DK1947187T5
(da)
|
2000-02-28 |
2011-10-24 |
Novartis Vaccines & Diagnostic |
Hybrid ekspression af neisserial-proteiner
|
|
GB0011108D0
(en)
*
|
2000-05-08 |
2000-06-28 |
Microscience Ltd |
Virulence gene and protein and their use
|
|
KR20030024811A
(ko)
|
2000-07-27 |
2003-03-26 |
칠드런즈 하스피틀 앤드 리써치 센터 앳 오클랜드 |
나이세리아 메닌지티디스에 의하여 유발되는 질병에 대한광범위하게 유효한 보호를 위한 백신
|
|
GB0107219D0
(en)
*
|
2001-03-22 |
2001-05-16 |
Microbiological Res Authority |
Immunogenic commensal neisseria sequences
|
|
GB0108024D0
(en)
*
|
2001-03-30 |
2001-05-23 |
Chiron Spa |
Bacterial toxins
|
|
RU2355704C2
(ru)
*
|
2001-04-17 |
2009-05-20 |
Новартис Вэксинс Энд Диагностикс, Инк |
Моноклональное антитело, направленное против gna33 пептида, и его применение
|
|
CN1306956C
(zh)
*
|
2001-04-17 |
2007-03-28 |
希龙公司 |
诱导功能活性抗体的脑膜炎球菌b抗原表位的分子模拟物
|
|
CU23245A1
(es)
|
2001-07-16 |
2007-10-17 |
Inst De Medicina Tropical Pedr |
CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS
|
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
|
ATE469915T1
(de)
|
2001-07-27 |
2010-06-15 |
Novartis Vaccines & Diagnostic |
Antikörper gegen das meningokokken adhäsin app
|
|
GB0121591D0
(en)
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
AU2003239125A1
(en)
|
2002-03-20 |
2003-10-08 |
Emory University |
Neisseria mutants, lipooligosaccharides and immunogenic compositions
|
|
CA2493124C
(en)
*
|
2002-08-02 |
2014-04-29 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
|
US7785608B2
(en)
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
|
CN1809380B
(zh)
|
2002-10-11 |
2010-05-12 |
启龙有限公司 |
广泛防御高毒性脑膜炎球菌谱系的多肽-疫苗
|
|
US7807802B2
(en)
|
2002-11-12 |
2010-10-05 |
Abbott Lab |
Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
|
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
ES2461350T3
(es)
*
|
2003-01-30 |
2014-05-19 |
Novartis Ag |
Vacunas inyectables contra múltiples serogrupos de meningococos
|
|
CU23237A1
(es)
|
2003-12-03 |
2007-09-26 |
Ct Ingenieria Genetica Biotech |
PROTEINA NMB1125 Y SU USO EN FORMULACIONES FARMACéUTICAS
|
|
GB0408977D0
(en)
|
2004-04-22 |
2004-05-26 |
Chiron Srl |
Immunising against meningococcal serogroup Y using proteins
|
|
LT2682126T
(lt)
|
2005-01-27 |
2017-02-27 |
Children`s Hospital & Research Center at Oakland |
Gna1870 pagrindu gaminamos pūslelių pavidalo vakcinos, skirtos plataus spektro apsaugai nuo neisseria meningitidis sukeltų ligų
|
|
JP2008530245A
(ja)
|
2005-02-18 |
2008-08-07 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド |
尿路病原性菌株由来の抗原
|
|
SI2351772T1
(sl)
|
2005-02-18 |
2016-11-30 |
Glaxosmithkline Biologicals Sa |
Proteini in nukleinske kisline iz Escherichia coli povezane z meningitisom/sepso
|
|
EP1856291A4
(en)
*
|
2005-03-04 |
2009-04-01 |
Verenium Corp |
NUCLEIC ACIDS AND PROTEINS, AND METHODS OF MAKING AND USING SAME
|
|
CU23578A1
(es)
|
2005-09-16 |
2010-09-30 |
Ct Ingenieria Genetica Biotech |
Proteína de la cápsida del virus dengue inductora de respuesta protectora y composición vacunal
|
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
|
CU23549A1
(es)
*
|
2005-12-29 |
2010-07-20 |
Ct Ingenieria Genetica Biotech |
Composiciones farmacéuticas que contienen la proteína nma0939
|
|
CN101479293A
(zh)
|
2006-06-29 |
2009-07-08 |
诺华有限公司 |
脑膜炎奈瑟球菌多肽
|
|
EP2586790A3
(en)
|
2006-08-16 |
2013-08-14 |
Novartis AG |
Immunogens from uropathogenic Escherichia coli
|
|
CU23630A1
(es)
|
2006-10-30 |
2011-02-24 |
Ct Ingenieria Genetica Biotech |
Moléculas peptídicas quiméricas con propiedades antivirales contra los virus de la familia flaviviridae
|
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
|
TW200902708A
(en)
|
2007-04-23 |
2009-01-16 |
Wyeth Corp |
Methods of protein production using anti-senescence compounds
|
|
GB0713880D0
(en)
|
2007-07-17 |
2007-08-29 |
Novartis Ag |
Conjugate purification
|
|
EP2886551A3
(en)
|
2008-02-21 |
2015-09-23 |
Novartis AG |
Meningococcal fhbp polypeptides
|
|
PL2411048T3
(pl)
|
2009-03-24 |
2020-11-16 |
Glaxosmithkline Biologicals Sa |
Adjuwantowe meningokokowe białko wiążące czynnik h
|
|
WO2010130896A2
(fr)
|
2009-05-14 |
2010-11-18 |
Sanofi Pasteur |
Procédé pour adjuver le lipopolysaccharide (lps) des bactéries à gram-négatif
|
|
CA2803239A1
(en)
|
2010-06-25 |
2011-12-29 |
Novartis Ag |
Combinations of meningococcal factor h binding proteins
|
|
RU2580620C2
(ru)
|
2010-08-23 |
2016-04-10 |
ВАЙЕТ ЭлЭлСи |
СТАБИЛЬНЫЕ КОМПОЗИЦИИ АНТИГЕНОВ Neisseria meningitidis rLP2086
|
|
WO2012032489A1
(en)
|
2010-09-10 |
2012-03-15 |
Wyeth Llc |
Non-lipidated variants of neisseria meningitidis orf2086 antigens
|
|
BR112013005626B1
(pt)
|
2010-09-10 |
2022-07-26 |
Glaxosmithkline Biologicals Sa |
Meningococo, processo para a preparação de uma cepa meningocócica, vesículas de membrana externa, composição farmacêutica imunogênica, e, uso de uma composição
|
|
CA2865745C
(en)
|
2012-03-09 |
2018-01-09 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
|
MX357538B
(es)
|
2012-06-14 |
2018-07-13 |
Novartis Ag |
Vacunas para meningococo de serogrupo x.
|
|
HK1205138A1
(en)
|
2012-07-27 |
2015-12-11 |
Institut National De La Santé Et De La Recherche Médicale (Inserm) |
Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
|
|
US9802987B2
(en)
|
2013-03-08 |
2017-10-31 |
Pfizer Inc. |
Immunogenic fusion polypeptides
|
|
RU2662968C2
(ru)
|
2013-09-08 |
2018-07-31 |
Пфайзер Инк. |
Иммуногенная композиция против neisseria meningitidis (варианты)
|
|
AU2016221318B2
(en)
|
2015-02-19 |
2020-06-25 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
WO2017137085A1
(en)
|
2016-02-11 |
2017-08-17 |
Sanofi Pasteur |
Meningitidis vaccines comprising subtilinases
|
|
US10183070B2
(en)
|
2017-01-31 |
2019-01-22 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
CA3059650C
(en)
*
|
2017-05-10 |
2023-12-19 |
Global Bioenergies |
Improved methods for producing isobutene from 3-methylcrotonic acid
|
|
US11464845B2
(en)
|
2017-07-21 |
2022-10-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Neisseria meningitidis immunogenic compositions
|
|
US20220081707A1
(en)
*
|
2018-07-25 |
2022-03-17 |
The Trustees Of Indiana University |
Diagnostic assay for a strain of neisseria meningitidis
|
|
EP4034157A1
(en)
|
2019-09-27 |
2022-08-03 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
CN113136444B
(zh)
*
|
2021-05-10 |
2024-04-19 |
临沂大学 |
医用食品中海氏肠球菌的微滴数字pcr检测方法
|
|
CN116162140B
(zh)
*
|
2022-07-19 |
2025-09-09 |
四川大学华西医院 |
一种幽门螺杆菌重组抗原蛋白SecG及其制备方法与应用
|
|
WO2025006737A1
(en)
|
2023-06-30 |
2025-01-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Genetically detoxified mutant of neisseria and outer membrane vesicle (omv) vaccine
|
|
CN119792504A
(zh)
*
|
2023-10-10 |
2025-04-11 |
康希诺生物股份公司 |
一种抗脑膜炎球菌的免疫组合物及其用途
|